Compound 451238 / Royal Marsden Hospital - LARVOL DELTA

Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - P1/2 | N=12 | Completed | Sponsor: Royal Marsden NHS Foundation Trust | Active, not recruiting ➔ Completed

Trial completion • Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • PD-L1

Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - P1/2; N=12; Active, not recruiting; Sponsor: Royal Marsden NHS Foundation Trust; Recruiting ➔ Active, not recruiting

Enrollment closed • Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • MRI • PD-L1

Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma (clinicaltrials.gov) - P1/2; N=12; Recruiting; Sponsor: Royal Marsden NHS Foundation Trust; Active, not recruiting ➔ Recruiting; Trial completion date: Feb 2022 ➔ Jan 2023; Trial primary completion date: Sep 2020 ➔ May 2022

Enrollment open • Trial completion date • Trial primary completion date • Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • MRI • PD-L1